1. Home
  2. VTAK

as of 12-01-2025 3:59pm EST

$2.05
$0.08
-3.76%
Stocks Health Care Medical/Dental Instruments Nasdaq

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

Chart Type:
Time Range:
Founded: 2002 Country:
United States
United States
Employees: N/A City: FORT MILL
Market Cap: 4.1M IPO Year: 2018
Target Price: N/A AVG Volume (30 days): 28.8K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -28.39 EPS Growth: N/A
52 Week Low/High: $1.49 - $15.68 Next Earning Date: 11-13-2025
Revenue: $730,000 Revenue Growth: 82.96%
Revenue Growth (this year): 822.86% Revenue Growth (next year): 168.42%

AI-Powered VTAK Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 81.13%
81.13%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest Catheter Precision Inc. News

VTAK Breaking Stock News: Dive into VTAK Ticker-Specific Updates for Smart Investing

All VTAK News

Share on Social Networks: